Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00245284 · ClinicalTrials.gov registry record

Predictor of Advanced Subclinical Atherosclerosis

A clinical trial of Coronary Artery Disease, sponsored by PreMD.

Completed
Registry status
600
Enrollment target
6
Study locations

NCT00245284 is a study of Coronary Artery Disease that has completed, run by PreMD. The registered enrollment target is 600 participants, below the 1,284-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (53% lower). The trial reports 6 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00245284, a study of Coronary Artery Disease, has completed, sponsored by PreMD.

COMPLETED
Registry status
600 participants
Enrollment target
6
Study locations

Study Summary

Evaluation of skin cholesterol for cardiovascular risk assessment in asymptomatic individuals at low, intermediate, or high risk based on Framingham Global Risk estimates. Carotid intima-media thickness (IMT), a surrogate marker for atherosclerotic burden, that independently predicts the occurrence of heart attack and stroke, will be the "gold standard" comparator. Hypothesis: Skin cholesterol, as measured by two non-invasive tests, correlates with CAD, as measured by CIMT in this population.

Conditions Studied

Coronary Artery Disease

Study Locations (6)

Illinois

  • Radiant Research - Chicago
  • University of Chicago - Chicago

Maryland

  • Johns Hopkins Hospital - Baltimore

Minnesota

  • University of Minnesota - Minneapolis

Pennsylvania

  • University od Pennsylvania - Philadelphia

Wisconsin

  • University of Wisconsin - Madison

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2005-09
Est. Completion 2006-05

Sponsor

PreMD

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00245284

The ClinicalTrials.gov registry entry for NCT00245284 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,284-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (53% lower). The listed sponsor is PreMD, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 0 interventions.

NCT00245284 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Illinois, Maryland, Minnesota.

Frequently Asked Questions

What is clinical trial NCT00245284 about?

NCT00245284 is a clinical study titled "Predictor of Advanced Subclinical Atherosclerosis". Evaluation of skin cholesterol for cardiovascular risk assessment in asymptomatic individuals at low, intermediate, or high risk based on Framingham Global Risk estimates. Carotid intima-media thickness (IMT), a surrogate marker for atherosclerotic burden, that independently predicts the occurrence ...

What is the current status of trial NCT00245284?

This trial is currently completed. The enrollment target is 600 participants. The study started on 2005-09. Estimated completion is 2006-05.

What conditions does trial NCT00245284 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

Who is sponsoring clinical trial NCT00245284?

This trial is sponsored by PreMD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00245284 being conducted?

This trial has 6 study locations across Illinois, Maryland, Minnesota, Pennsylvania, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Coronary Artery Disease

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.